HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic options for transfusion related acute lung injury; the potential of the G2A receptor.

Abstract
Priming of polymorphonuclear leukocytes (PMNs) enhances their adhesion to endothelium, the release of their granule content and their production of reactive oxygen species. These effects are etiological in transfusion related acute lung injury (TRALI) and many clinically important mediators of TRALI prime PMNs. A priming activity that develops over time in stored blood products has been shown to be due to the accumulation of lysophospatidylcholines (lyso-PCs) and has been found to be related clinically to TRALI. Lyso- PCs prime PMNs activating the G2A receptor and several inhibitors of this receptor, which could potentially be therapeutic in TRALI, have been identified. Recent work has described early steps in the signaling from the G2A receptor which has revealed potential targets for novel antagonists of lyso-PC mediated priming via G2A. Additionally, characterization of the process by which lyso-PCs are generated in stored blood products could allow development of inhibitors and additive solutions to block their formation in the first place.
AuthorsMichael A Ellison, Daniel R Ambruso, Christopher C Silliman
JournalCurrent pharmaceutical design (Curr Pharm Des) Vol. 18 Issue 22 Pg. 3255-9 ( 2012) ISSN: 1873-4286 [Electronic] United Arab Emirates
PMID22621271 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Cell Cycle Proteins
  • G2A receptor
  • Lysophosphatidylcholines
  • Reactive Oxygen Species
  • Receptors, G-Protein-Coupled
Topics
  • Acute Lung Injury (etiology, therapy)
  • Animals
  • Blood Preservation (methods)
  • Blood Transfusion (methods)
  • Cell Cycle Proteins (antagonists & inhibitors, metabolism)
  • Drug Design
  • Humans
  • Lysophosphatidylcholines (metabolism)
  • Neutrophils (metabolism)
  • Reactive Oxygen Species (metabolism)
  • Receptors, G-Protein-Coupled (antagonists & inhibitors, metabolism)
  • Time Factors
  • Transfusion Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: